This conference brings together drug development project management professionals with senior management and executives from pharmaceutical and biotechnology companies. The aim is to share understanding of how Portfolio, Program, and Project Management (P3M) can best contribute to the delivery of value at the corporate level. People and process aspects of P3M will addressed, as well as how senior executives and project professionals can most effectively engage in the delivery of high value drugs to market. The conference will be proceeded by a half-day workshop on managing uncertainty in drug development projects. In addition, there will be a networking dinner following the workshop.